DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20175372

A study of the association of premature androgenetic alopecia with metabolic syndrome and coronary artery disease

Jaskaran Batra, Niti Khunger, Khushpreet Kaur Maan

Abstract


Background: Androgenetic alopecia (AGA) is a common form of patterned hair loss characterized by transformation of terminal hair of the scalp to vellous hair mediated mainly by androgens. Premature androgenetic alopecia can be defined as androgenetic alopecia developing before 35 years of age and presenting with at least stage 2 of Norwood-Hamilton classification. Premature AGA not only adds to psychological stress but is also reported as a risk factor for cardiovascular diseases, metabolic syndrome and carcinoma prostrate. In many subsequent studies, AGA has been shown to be associated with several diseases such as insulin resistance (IR), abnormal serum lipid profiles and obesity.

Methods: Various parameters of metabolic syndrome were measured in 75 male patients of AGA in the department of dermatology, Safdarjung hospital from June 2015 to April 2016. ECG and echocardiography was done in all patients to look for any evidence of premature coronary artery disease.

Results: In our study grade III and IV of AGA were the most common types (32% each). We found the prevalence of metabolic syndrome to be 8% in our patients with premature androgenetic alopecia in accordance with the NCEP ATP III guidelines. There was a significant positive correlation between grade of androgenetic alopecia and metabolic syndorme in our patients (p=0.049).

Conclusions: The prevalence of metabolic syndrome was not increased as compared to general population.


Keywords


Metabolic syndrome, Androgenetic alopecia

Full Text:

PDF

References


Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5- alpha reductase genes. J Invest Dermatol. 1998;110:849–53.

Sharma L, Dubey A, Gupta PR, Agrawal A. Androgenetic alopecia and risk of coronary artery disease. Indian Dermatol Online J. 2013;4:283–7.

Norwood OT. Male pattern baldness classification and incidence. South Med J. 1975;68:1359–65.

Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17:220–2.

Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol. 2011;21:79–82.

Misra A, Khurana L. The metabolic syndrome in South Asians. Epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7:497–514.

Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Cent Eur J Public Health. 2006;14:78–81.

Chumlea WC, Rhodes T, Girman CJ, Johnson-Levonas A, Lilly FR, Wu R, et al. Family history and risk of hair loss. Dermatology. 2004;209:33-9.

Arias-Santiago S, Arrabal-Polo MA, Buendía-Eisman A, Arrabal-Martín M, Gutiérrez-Salmerón MT, Girón-Prieto MS, et al. Androgenetic alopecia as an early marker of benign prostatic hyperplasia. J Am Acad Dermatol. 2012;66:401–8.

Cotton SG, Nixon JM, Carpenter RG, Evans DW. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J. 1972;34:458–64.

Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) J Am Med Assoc. 2001;285:2486–97.

Wolfe AM, Vacek JL. Myocardial Infarction in the young. Chest. 1988;94:926-30.

Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, et al. Acute myocardial infarction in the young - The University of Michigan experience. Am Heart J. 2002;143:56-62.

Wang TL, Zhou C, Shen YW, Wang XY, Ding XL, Tian S, et al. Prevalence of androgenetic alopecia in China: A community-based study in six cities. Br J Dermatol. 2010;162(4):843-7.

Krupa Shankar D, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: Population-based study in 1,005 subjects. Int J Trichol. 2009;1(2):131-3.

Banger HS, Malhotra SK, Singh S, Mahajan M. Is Early Onset Androgenic Alopecia a Marker of Metabolic Syndrome and Carotid Artery Atherosclerosis in Young Indian Male Patients? Int J Trichol. 2015;7:141-7

Chakrabarty S, Hariharan R, Gowda D, Suresh H. Association of premature androgenetic alopecia and metabolic syndrome in a young Indian population. Int J Trichol. 2014;6:50-3.

Acibucu F, Kayatas M, Candan F. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia. Singapore Med J. 2010;51:931–6.

Guzzo CA, Margolis DJ, Johnson J. Lipid profiles, alopecia, and coronary disease: any relationship? Dermatol Surg. 1996; 22:481.

Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol. 2011;21:79–82.

Nabaie L, Kavand S, Robati RM, Sarrafi-Rad N, Kavand S, et al. Androgenic alopecia and insulin resistance: are they really related?”. Clin Exp Dermatol. 2009;34:694-7.

Chakrabarty S, Hariharan R, Gowda D, Suresh H. Association of premature androgenetic alopecia and metabolic syndrome in a young Indian population. Int J Trichol. 2014;6:50-3.

Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol. 2010;163:371-7.

Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr. 2007;2:267-75.

Sawant AM, Shetty D, Mankeshwar R, Ashavaid TF. Prevalence of dyslipidemia in young adult Indian population. J Assoc Physicians India. 2008;56:99-102.

Dogramaci AC, Balci DD, Balci A, Karazincir S, Savas N, Topaloglu C, Yalcin F. Is androgenetic alopecia a risk for atherosclerosis? J Eur Acad Dermatol Venereol. 2009;23(6):673-7.

Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol. 2008;167:676-83.